- $8.62m
- $7.82m
- $4.45m
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist
Biomerica rises after securing first major European order for stomach infection test
Brief: Biomerica Receives First Commercial Order For Its H. Pylori Test (Hp Detect™) From One Of The Largest Clinical Laboratory Chains In Europe
Brief: Biomerica Receives Mhra Registration For Hp+Detect™, Allowing Commercial Sales In Great Britain
Medical diagnostics firm Biomerica's Q2 revenue falls amid product transition
Brief: Biomerica Reports Second Quarter Fiscal 2026 Financial Results
Brief: Biomerica Q2 Net Income USD -1.32 Million
Brief: Biomerica Announces CMS Medicare Payment Rate Of $300 For Revolutionary Infoods® IBS Test
Brief: Biomerica Expands Contract Development And Manufacturing Services To Meet Growing Market Demand
Brief: Henry Schein And Biomerica Enter Into Marketing Services Agreement For Biomerica's inFoods IBS Test In The US
Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity
Brief: Gary Huff, Former CEO Of Labcorp Diagnostics, Appointed To Biomerica Board Of Directors
Brief: Biomerica Launches AI-Powered inFoods® IBS Navigator for Personalized Therapy